Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.
Prolific Machines has raised $55.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Prolific Machines's investors include Mayfield Fund, SOSV, Breakthrough Energy Ventures, IndieBio, Breyer Capital.
Prolific Machines is headquartered in Emeryville, United States.
Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.
Prolific Machines is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prolific Machines — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/prolific-machines. Accessed October 17, 2026.
VCBacked. (2024). Prolific Machines — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/prolific-machines
{{cite web |title=Prolific Machines — Funding & Investors |url=https://www.vcbacked.co/company/prolific-machines |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated